Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT03494738
Development of an Epigenetic Biomarker for Prediction of Fetal Alcohol Spectrum Disorder
Sponsor: CAMC Health System
View on ClinicalTrials.gov
Summary
The objective of the study is to validate epigenetic changes as biomarkers in a prospective sampling of newborn blood samples collected at birth (umbilical cord blood) and during routine screening (heel stick blood) in newborns concurrently tested for alcohol exposure levels by PEth blood spot testing.
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
600
Start Date
2018-04-12
Completion Date
2022-12-31
Last Updated
2026-08-20
Healthy Volunteers
No
Conditions
Locations (1)
CAMC - Women and Children's Hospital
Charleston, West Virginia, United States